Results 621-640 of 1,131,256 for in 'Dáil debates' OR (speaker:Catherine Byrne OR speaker:Josepha Madigan OR speaker:Bernard Durkan OR speaker:Jennifer Carroll MacNeill OR speaker:Peter Burke OR speaker:Darragh O'Brien OR speaker:Patrick Costello OR speaker:Duncan Smith OR speaker:Joe McHugh OR speaker:John Brady OR speaker:Dara Calleary OR speaker:Micheál Martin OR speaker:Maurice Quinlivan OR speaker:Catherine Connolly OR speaker:Kathleen Funchion OR speaker:Gary Gannon OR speaker:Damien English OR speaker:Sorca Clarke OR speaker:Catherine Byrne6 OR speaker:Brendan Smith OR speaker:Noel Grealish OR speaker:Denise Mitchell OR speaker:Carol Nolan OR speaker:Neale Richmond OR speaker:Brian Stanley OR speaker:Frank Feighan OR speaker:Mick Barry OR speaker:Mairead Farrell OR speaker:Thomas Gould OR speaker:Catherine Byrne7 OR speaker:Catherine Murphy OR speaker:Ossian Smyth OR speaker:Seán Ó Fearghaíl OR speaker:Simon Harris OR speaker:Aindrias Moynihan OR speaker:Neasa Hourigan) in 'Committee meetings'

Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (17 Oct 2024)

Maurice Quinlivan: They are excluded in that context also. I have a close relative who is on methadone for cancer treatment.

Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (17 Oct 2024)

Maurice Quinlivan: Can Mr. McBrien give us some examples? I represent Limerick City and we have a huge crisis in our emergency department. I would hate to think, as the witness has just explained to us, and I do not mean to downplay someone who has an addiction problem, that doctors might be taken away from a crisis intervention to prescribe methadone. Does that happen all the time?

Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (17 Oct 2024)

Maurice Quinlivan: To be crystal clear, for us to change that and what the nurse can do we need to change the legislation.

Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (17 Oct 2024)

Maurice Quinlivan: I thank Mr. McBrien for that. I agree with Dr. Kelly's issue regarding pay tenure, career progression, workload in the profession and other workers in addiction services and some of the remuneration and perks. It is not necessarily the case for nursing but some of the people working in that sector have not had a pay rise for a number of years, ten or 11 years in some cases. As I said, I am...

Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (17 Oct 2024)

Maurice Quinlivan: Will Dr. Kelly briefly explain how he sees independent oversight working? He also referenced that in his opening statement.

Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (17 Oct 2024)

Maurice Quinlivan: Professor Comiskey addressed stigma and how we deal with it. What are the easy wins on that front?

Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (17 Oct 2024)

Neasa Hourigan: I welcome our witnesses. I want to touch on stigma but before that I will go back to nurse prescribing. A lot of the discussion we are having today reminds me of when I followed the nurse prescribing journey in diabetes. It reminds me of that a lot, in that it is a lifestyle-based treatment and is very much about who you meet when you go into a clinic. At the front line that is often...

Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (17 Oct 2024)

Neasa Hourigan: I presume we should have non-elective modules within training for all medical professionals. Would that be specifically on addiction or would it be more useful for it be about what trauma-centred care looks like?

Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (17 Oct 2024)

Neasa Hourigan: Would the other witnesses like to come in on addiction versus trauma led?

Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (17 Oct 2024)

Neasa Hourigan: The research suggests that when you are on the front line, those attitudes become more prevalent.

Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (17 Oct 2024)

Neasa Hourigan: That would take care of all of our new cohort. There are hundreds of thousands of people working in services that are central or tangential to our health service. How do we hit all of them? Do we need to get everybody into a continuing professional development course on addiction and trauma-like care?

Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (17 Oct 2024)

Neasa Hourigan: How far along are we on that journey?

Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (17 Oct 2024)

Neasa Hourigan: Working in an emergency department is different from working in a laboratory.

Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (17 Oct 2024)

Neasa Hourigan: I will return to the question of the inspection of services. I am a member of the Joint Committee on Health, where we talk a lot about the inspection side of things in the context of oversight, performance indicators and outcomes. Who would do that? Perhaps that is not fair. What kind of a body could the witnesses imagine undertaking that piece of work?

Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (17 Oct 2024)

Neasa Hourigan: Could Dr. Kelly give me an idea of the breadth and level of that service? Would it include all the third-party and NGO services?

Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (17 Oct 2024)

Neasa Hourigan: Would it influence how drug task forces work?

Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (17 Oct 2024)

Neasa Hourigan: It is crazy.

Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (17 Oct 2024)

Neasa Hourigan: By proxy, there would be a benchmark that you could fall below and therefore-----

Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (17 Oct 2024)

Neasa Hourigan: I have a question about data which struck me when talking about the prisons. I was reading something about it. Do we have the data about how many persons are eligible for OST or who would be appropriate for OST? Not somebody who has tried a drug once, but somebody who would benefit from OST. How many are actually in treatment? One statistic I read stated 35% of people who should be in...

Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (17 Oct 2024)

Neasa Hourigan: Yes, of course. To be honest, my question was not just what the number is but whether we are recording the data. When I ask a question about health, I am often told it is not recorded. As a result, I was wondering whether we have a sense of the data.